SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use
16 references·0 citing·34 second hop
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use (2023)Attenuation of psilocybin mushroom effect…Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial (2023)Psilocybin-assisted therapy f…Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Single-Dose Psilocybin for a …Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up (2022)Efficacy and safety of psiloc…Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review (2022)Drug-drug interactions betwee…Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…Serotonin toxicity of serotonergic psychedelics (2021)Serotonin toxicity of seroton…Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects (2021)Acute Effects of Psilocybin A…Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Effects of Psilocybin-Assiste…Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (2019)Psychedelic effects of psiloc…Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Quality of Acute Psychedelic …Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psilocybin with psychological…Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens (2016)Receptor interaction profiles…Psychedelics (2016)PsychedelicsMystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Mystical-type experiences occ…Hallucinogens (2004)HallucinogensChronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans (1996)Chronic Administration of Ser…The varieties of religious experience: A study in human nature. (1902)The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form (1994)Psychological Assessment Resources (1995)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (2015)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Tests for comparing elements of a correlation matrix. (1980)Psychedelics and the essential importance of context (2018)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. (1998)Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies (2020)Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice (2021)Psychedelics reopen the social reward learning critical period (2023)A RATING SCALE FOR DEPRESSION (1960)Manual for the State-Trait Anxiety Inventory (1970)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients (1996)The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression (2003)Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial (2022)Must Psilocybin Always “Assist Psychotherapy”? (2023)A New Depression Scale Designed to be Sensitive to Change (1979)Psilocybin desynchronizes the human brain (2024)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)Human hallucinogen research: guidelines for safety (2008)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)
this work references cited by second hop

References

  • 2016Psychedelics1,757 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2020Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder1,296 cited
  • 2004Hallucinogens1,208 cited
  • 2022Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression1,164 cited
  • 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
  • 2008Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later901 cited
  • 2018Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression806 cited
  • 2019Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels513 cited
  • 2022Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up423 cited
  • 2016Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens377 cited
  • 2021Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects184 cited
  • 2023Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial165 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1996
Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans
157 cited
  • 2021Serotonin toxicity of serotonergic psychedelics138 cited
  • 2022Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review88 cited
  • Cited by

    No citing works inside the corpus for this window.